MedTrace has received a U.S. patent covering its PC MT-100 system for producing oxygen-15 (O-15), a myocardial perfusion imaging radiotracer.
The P3 MT-100 automated manufacturing system is currently in use at several hospitals around the world as part of a phase III clinical trial evaluating the diagnostic accuracy and safety of O-15 for visualizing myocardial blood flow. The system is designed to enable hospitals to produce O-15 tracer injections at the point of care without relying on third-party suppliers for radiopharmaceuticals, MedTrace said.
